id: obesity_individual_to_NEW:fatty_liver_syndrome
name: Obesity â†’ Fatty Liver Syndrome
from_node:
  node_id: obesity_individual
  node_name: Obesity
to_node:
  node_id: NEW:fatty_liver_syndrome
  node_name: Fatty Liver Syndrome
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Obesity leads to excess adipose tissue accumulation, resulting in increased
  circulating free fatty acids and chronic low-grade inflammation'
- 'Step 2: Elevated free fatty acids are taken up by hepatocytes, exceeding the liver''s
  capacity for fatty acid oxidation and export'
- 'Step 3: Excess lipids accumulate as triglycerides within hepatocytes, leading to
  hepatic steatosis (fatty liver)'
- 'Step 4: Continued lipid accumulation and associated oxidative stress can progress
  to hepatic fibrosis and eventual cirrhosis'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: M. Han 2020. "Noninvasive Tests (NITs) for Hepatic Fibrosis in
    Fatty Liver Syndrome." Life.
  supporting_citations: []
description: Obesity is a primary driver of fatty liver syndrome, as the high prevalence
  of obesity is directly linked to the emerging global health problem of fatty liver
  disease. The accumulation of excess adipose tissue leads to increased lipid deposition
  in the liver, which can progress to hepatic fibrosis and cirrhosis over time.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: Alcohol use disorder
  direction: strengthens
  strength: strong
  description: Alcohol use disorder is identified as a co-contributing factor alongside
    obesity in the development of fatty liver syndrome
